Publications
-
Title & Authors Journal Publication Date

De novo-designed pMHC binders facilitate T cell-mediated cytotoxicity toward cancer cells.


Johansen KH, Wolff DS, Scapolo B, Fernández-Quintero ML, Risager Christensen C, Loeffler JR, Rivera-de-Torre E, Overath MD, Kjærgaard Munk K, Morell O, Viuff MC, Lacunza I, Damm Englund AT, Due M, Gharpure A, Forli S, Rodriguez Pardo C, Tamhane T, Qingjie Andersen E, Haldrup Björnsson K, Fernandes JS, Voss LF, Thumtecho S, Ward AB, Ormhøj M, Reker Hadrup S, Jenkins TP.
Science July 24, 2025

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines.


Bangaru S, Jackson AM, Copps J, Fernández-Quintero ML, Torres JL, Richey ST, Nogal B, Sewall LM, Torrents de la Peña A, Rehman A, Guebre-Xabier M, Girard B, Das R, Corbett-Helaire KS, Seder RA, Graham BS, Edwards DK, Patel N, Smith G, Ward AB.
Cell Rep July 22, 2025

Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift.


Song G, Yuan M, Liu H, Capozzola T, Lin RN, Torres JL, He WT, Musharrafieh R, Dueker K, Zhou P, Callaghan S, Mishra N, Yong P, Anzanello F, Avillion G, Vo AL, Li X, Zhang Y, Makhdoomi M, Feng Z, Zhu X, Peng L, Nemazee D, Safonova Y, Briney B, Ward AB, Burton DR, Wilson IA, Andrabi R.
Cell Rep July 22, 2025

Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein.


Feng Z, Huang J, Baboo S, Diedrich JK, Bangaru S, Paulson JC, Yates JR 3rd, Yuan M, Wilson IA, Ward AB.
Cell Rep July 22, 2025

Structural mechanisms behind the neutralisation of long-chain α-neurotoxins by broadly neutralising V(H)Hs discovered using a consensus antigen.


Damsbo A, Burlet NJ, Fernández-Quintero ML, Benard-Valle M, Overath MD, Guadarrama-Martínez A, Vlamynck A, Bisbo I, Villalobos C, Tulika T, Alagón A, Loeffler JR, Ward AB, Boddum K, Morth JP, Rivera-de-Torre E, Laustsen AH.
Commun Chem July 19, 2025

Pan-H7 influenza human antibody virus neutralization depends on avidity and steric hindrance.


Gilchuk IM, Dong J, Irving RP, Buchman CD, Armstrong E, Turner HL, Li S, Ward AB, Carnahan RH, Crowe JE Jr.
JCI Insight July 8, 2025

Isolation of genetically diverse influenza antibodies highlights the role of IG germline gene variation and informs the design of population-comprehensive vaccine strategies.


Fischer AA, Corcoran M, Brouwer PJM, Chernyshev M, Gillespie RA, Nicoletto A, Loeffler JR, Ferguson JA, Rodriguez AJ, Narang S, van Gils MJ, Castro Dopico X, Kanekiyo M, Ward AB, Han J, Karlsson Hedestam GB.
bioRxiv July 7, 2025

A single residue change only differing by an atomic group can drive imprinting to influenza.


Sun J, Jo G, Troxell CA, Fu Y, Hoezl R, Lv H, Abozeid HH, Teo QW, Pholcharee T, McGrath JJC, Changrob S, Nelson SA, Yasuhara A, Huang M, Zheng NY, Chervin JC, Li L, Fernández-Quintero ML, Loeffler JR, Rodriguez AJ, Huang J, Swanson OM, Balmaseda A, Kuan G, Campredon L, Allen EK, Neumann G, Wu NC, Kawaoka Y, Krammer F, Thomas PG, Gordon A, Ward AB, Han J, Wilson PC.
Res Sq July 7, 2025

Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion.


Rodrigues KA, Zhang YJ, Lam J, Aung A, Morgan DM, Romanov A, Maiorino L, Yousefpour P, Gibson G, Ozorowski G, Gregory JR, Amlashi P, Van R, Buckley M, Ward AB, Schief WR, Love JC, Irvine DJ.
Sci Transl Med June 18, 2025

Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization.


Ghosh AR, Habib R, Mishra N, Roark RS, Akauliya M, Albowaidey AA, Allen JD, Amereh K, Avillion G, Bottermann M, Liang B, Chaudhary N, Callaghan S, Dye J, Li X, Ellis-Pugh JR, Chowdhury RR, James NE, Liu X, Maiorino L, Maldonado P, Nedellec R, Oberoi P, Sowers KJ, Park Y, Prum T, Rodriguez L, Ssozi M, Torres J, Walsh AA, Warner JE, Weldon SR, Xu L, Wiehe K, Crispin M, Ward AB, Nair U, Hahn BH, Burton DR, Shapiro L, Kwong PD, Irvine DJ, Andrabi R, Shaw GM, Batista FD.
bioRxiv June 17, 2025

Virus glycoprotein nanodisc platform for vaccine design.


Rantalainen K, Liguori A, Ozorowski G, Flynn C, Steichen JM, Swanson O, Madden PJ, Baboo S, Phulera S, Gharpure A, Lu D, Kalyuzhniy O, Skog P, Terada S, Shil M, Diedrich JK, Georgeson E, Tingle R, Eskandarzadeh S, Lee WH, Alavi N, Goodwin D, Kubitz M, Amirzehni S, Himansu S, Sok D, Lee JH, Yates JR 3rd, Paulson JC, Crotty S, Schiffner T, Ward AB, Schief WR.
bioRxiv June 16, 2025

Antigenic and EM characterization of the Chiron experimental hepatitis C virus vaccine.


Hung SH, Torres JL, Chen F, Giang E, Ward AB, Law M.
Vaccine June 11, 2025

Germline-encoded recognition of peanut underlies development of convergent antibodies in humans.


Marini-Rapoport O, Andrieux L, Keswani T, Zong G, Duchen D, Yaari G, Min J, Lytle IR, Rosenberg AF, Fucile C, Kobie JJ, Piepenbrink MS, Sun T, Martin VM, Yuan Q, Shreffler WG, Seppo AE, Järvinen KM, Loeffler JR, Ward AB, Kleinstein SH, Pedersen LC, Fernández-Quintero ML, Mueller GA, Patil SU.
Sci Transl Med June 11, 2025

Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer.


Schleich FA, Bale S, Guenaga J, Ozorowski G, Àdori M, Lin X, Castro Dopico X, Wilson R, Chernyshev M, Cotgreave AT, Mandolesi M, Cluff J, Doyle ED, Sewall LM, Lee WH, Zhang S, O'Dell S, Healy BS, Lim D, Lewis VR, Ben-Akiva E, Irvine DJ, Doria-Rose NA, Corcoran M, Carnathan D, Silvestri G, Wilson IA, Ward AB, Karlsson Hedestam GB, Wyatt RT.
Immunity June 10, 2025

Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.


Matsuda K, Harrison M, Wettstein E, Pederson J, Pullano AA, Bolkhovitinov L, Kim B, Steinberg I, Griesman T, Stuccio S, Rogan D, Patamawenu A, Shofner T, Wright NE, Webber JD, Van't Veer F, Roenicke R, Koory E, Roeder PM, Ober E, Leach B, Tsybovsky Y, Stephens T, Del Moral-Sanchez I, Bontjer I, McGinnes-Cullen LW, Chu E, Liang J, Torres JL, Lin RN, Tran AS, Dziubla G, Serebryannyy L, Narpala S, Lin B, Castro M, Ozorowski G, Ward AB, Sanders RW, Kwong PD, Guenaga J, Wyatt R, Morrison T, Connors M.
Nat Commun June 3, 2025

Local structural flexibility drives oligomorphism in computationally designed protein assemblies.


Khmelinskaia A, Bethel NP, Fatehi F, Mallik BB, Antanasijevic A, Borst AJ, Lai SH, Chim HY, Wang JY', Miranda MC, Watkins AM, Ogohara C, Caldwell S, Wu M, Heck AJR, Veesler D, Ward AB, Baker D, Twarock R, King NP.
Nat Struct Mol Biol June 1, 2025

Many naturally occurring protein assemblies have dynamic structures that allow them to perform specialized functions. Although computational methods for designing novel self-assembling proteins have advanced substantially over the past decade, they primarily focus on designing static structures. Here we characterize three distinct computationally designed protein assemblies that exhibit unanticipated structural diversity arising from flexibility in their subunits. Cryo-EM single-particle reconstructions and native mass spectrometry reveal two distinct architectures for two assemblies, while six cryo-EM reconstructions for the third likely represent a subset of its solution-phase structures. Structural modeling and molecular dynamics simulations indicate that constrained flexibility within the subunits of each assembly promotes a defined range of architectures rather than nonspecific aggregation. Redesigning the flexible region in one building block rescues the intended monomorphic assembly. These findings highlight structural flexibility as a powerful design principle, enabling exploration of new structural and functional spaces in protein assembly design.

Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope.


Bick MV, Puig E, Beauparlant D, Nedellec R, Burton I, Ardaghi K, Zalunardo TR, Bastidas R, Li X, Guenaga J, Lee WH, Wyatt R, Zhu W, Crispin M, Ozorowski G, Ward AB, Burton DR, Hangartner L.
Cell Rep April 22, 2025